Literature DB >> 28465749

Expression of Bcl-2, Melan A and HMB-45 in Dysplastic Nevi.

Oana Maria Patrascu1, Mariana Costache1, Adrian Vasile Dumitru1, Corina Nicoleta Mehotin1, Maria Sajin1, Anca Mihaela Lazaroiu1.   

Abstract

BACKGROUND: From the first recognition of dysplastic nevi as a pathology per se, many debates have been raised and many histological and immunohistological studies have been conducted in order to establish the true significance of these lesions. Therefore, the aim of this study was to establish if there is a correlation between HMB-45, Melan A and Bcl-2 expression and the grade of dysplasia, as well as between the marker's staining patterns.
MATERIAL AND METHODS: Ten dysplastic nevi from six female patients were selected and their histological features (size, dysplasia), as well as the immunohistological staining patterns, were studied (HMB-45, Melan A, Bcl-2). The Pearson correlation coefficient and regression was calculated with Windows Excel Data Analysis.
RESULTS: We demonstrated that there was a notable correlation between the dysplasia and the size of the lesions (r(8)= 0.62 with p-value= 0.052), and also between Melan A and Bcl-2 (a r(6)= 0.73, p<0.05), but we did not obtain a statistically significant correlation between other features (p>0.05).
CONCLUSIONS: We can affirm, at least in our cases, there is a correlation between the grade of dysplasia and the size of the lesion, and also, that there is a correlation between Melan A and Bcl-2 staining, explained by MITF gene. These results were only partial concordant with those in other studies, therefore a larger number of cases is recommended to be further analyzed in order to clearly draw a conclusion.

Entities:  

Year:  2016        PMID: 28465749      PMCID: PMC5394496     

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  18 in total

1.  Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanoma.

Authors:  M Berset; J P Cerottini; D Guggisberg; P Romero; F Burri; D Rimoldi; R G Panizzon
Journal:  Int J Cancer       Date:  2001-01-20       Impact factor: 7.396

2.  The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management.

Authors:  Keith Duffy; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2012-07       Impact factor: 11.527

Review 3.  Molecular aspects of melanocytic dysplastic nevi.

Authors:  Mahmoud Rezk Abd-Elwahed Hussein; Gary Stewart Wood
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

4.  HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma.

Authors:  B R Smoller; N S McNutt; A Hsu
Journal:  Am J Surg Pathol       Date:  1989-08       Impact factor: 6.394

5.  The role of Bcl-2 family members in the progression of cutaneous melanoma.

Authors:  Jason A Bush; Gang Li
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

6.  HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups.

Authors:  I Ahmed; M Piepkorn; D E Goldgar; L A Cannon-Albright; L J Meyer; M H Skolnick; J J Zone
Journal:  J Cutan Pathol       Date:  1991-08       Impact factor: 1.587

7.  Myeloid leukemia-1 expression in benign and malignant melanocytic lesions.

Authors:  Ronald P C Wong; Shahram Khosravi; Magdalena Martinka; Gang Li
Journal:  Oncol Rep       Date:  2008-04       Impact factor: 3.906

8.  Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.

Authors:  V A Tron; S Krajewski; H Klein-Parker; G Li; V C Ho; J C Reed
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

9.  Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions.

Authors:  Bonnie E Gould Rothberg; Christopher B Moeder; Harriet Kluger; Ruth Halaban; David E Elder; George F Murphy; Alexander Lazar; Victor Prieto; Lynn McDivitt Duncan; David L Rimm
Journal:  Mod Pathol       Date:  2008-06-13       Impact factor: 7.842

10.  Nuclear ING2 expression is reduced in human cutaneous melanomas.

Authors:  F Lu; D L Dai; M Martinka; V Ho; G Li
Journal:  Br J Cancer       Date:  2006-06-06       Impact factor: 7.640

View more
  1 in total

1.  miR-7-5p Promotes Hepatic Stellate Cell Activation by Targeting Fibroblast Growth Factor Receptor 4.

Authors:  Shuxia Tian; Min Chen; Bing Wang; Yonglong Han; Haonan Shang; Junming Chen
Journal:  Gastroenterol Res Pract       Date:  2020-06-10       Impact factor: 2.260

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.